![John Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Hansen
Vorstandsvorsitzender bei
MABVAX THERAPEUTICS HOLDINGS, INC.
Profil
John David Hansen was the founder of Xenerex Biosciences, founded in 2001, where the titles held included President & Chief Operating Officer from 2009 to 2015.
Mr. Hansen is also the founder of MabVax Therapeutics, Inc...
Mr. Hansen currently holds the position of Chief Executive & Financial Officer & Secretary at MabVax Therapeutics Holdings, Inc. Former positions include President, Chief Executive Officer & Director at Telik, Inc.; Director-Business Development & Marketing at Dura Pharmaceuticals, Inc. from 1989 to 1998; and Senior Vice President-Corporate Development at Avanir Pharmaceuticals, Inc. from 1998 to 2006.
Education includes an undergraduate degree from the University of Oregon, conferred in 1974.
Aktive Positionen von John Hansen
| Unternehmen | Position | Beginn |
|---|---|---|
| MABVAX THERAPEUTICS HOLDINGS, INC. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von John Hansen
| Unternehmen | Position | Ende |
|---|---|---|
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Vertrieb & Marketing | 01.09.1998 |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Vorstandsvorsitzender | - |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developed and commercialized immunotherapeutics for the treatment of cancer | Gründer | - |
Xenerex Biosciences
 Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing human monoclonal antibodies | Gründer | - |
Ausbildung von John Hansen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developed and commercialized immunotherapeutics for the treatment of cancer | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenerex Biosciences
Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing human monoclonal antibodies | Commercial Services |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes immunotherapeutics for the treatment of cancer | Health Technology |
